Recombinant Human IL-4 Protein 204-IL-010: R&D Systems

Por um escritor misterioso
Last updated 12 março 2025
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Human IL-4 protein (204-IL) is manufactured by R&D Systems, over 97% purity. Cited in over 387 publications. Reproducible results in bioactivity assays. Learn More
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 GMP Protein, CF 204-GMP-050: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 (CHO-expressed) Protein 6507-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4R alpha Fc Chimera Avi-tag Protein, CF AVI7700-050: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-3 Protein 203-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
IJMS, Free Full-Text
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment - ScienceDirect
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Mouse IL-4 Protein 404-ML-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
DC-STAMP/TM7SF4 Antibody (788524) (MAB7824): Novus Biologicals
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant human IL-4 Receptor alpha protein (ab225862)
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
R Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed), CF 50 μg: Recombinant
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Human IL-4 Biotinylated Antibody BAF204: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Recombinant Human IL-4 Protein 204-IL-010: R&D Systems
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells

© 2014-2025 citytv24.com. All rights reserved.